PTHL Share Price Performance
US$0.73
-4.07 (-84.79%)
Price US$0.73
Share PriceUS$0.73
Pheton Holdings Ltd Stock Price
- 0 Narratives written by author
- 1 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
PTHL Community Narratives
There are no narratives available yet.
Recent PTHL News & Updates
Pheton Holdings Ltd Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.027
- Gross Margin
- 85.04%
- Net Profit Margin
- -147.39%
- Debt/Equity Ratio
- 4.0%
Pheton Holdings Ltd Competitors
Snowflake Analysis
About PTHL
- Founded
- 1998
- Employees
- 10
- CEO
- WebsiteView website
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is headquartered in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 0%
- 3 Months: 16.8%
- 1 Year: 25.7%
- Year to Date: 26.2%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. More promisingly, the market is up 26% over the past year. Earnings are forecast to grow by 27% annually. Market details ›